Pediatrix Medical Group, Inc. announced that its board of directors has elected James D. Swift, M.D., the Company's chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.2 USD | -3.30% | -3.53% | -11.83% |
05-07 | Transcript : Pediatrix Medical Group, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q1 Revenue $495.1M, vs. Street Est of $500.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.83% | 702M | |
-28.75% | 70.3B | |
+2.04% | 27.46B | |
-6.19% | 17.8B | |
+2.32% | 17.46B | |
+2.10% | 15.46B | |
+7.06% | 13.49B | |
+10.80% | 13.06B | |
+71.31% | 12.96B | |
+75.96% | 12.56B |
- Stock Market
- Equities
- MD Stock
- News Pediatrix Medical Group, Inc.
- Pediatrix Medical Group, Inc. Announces Board Changes